[EN] SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS<br/>[FR] SPIRO-INDOLINES EN TANT QU'ANTAGONISTES DU RECEPTEUR Y5
申请人:MERCK & CO INC
公开号:WO2000027845A1
公开(公告)日:2000-05-18
Compounds of general structural formula (I) such as that shown in structural formula (II) are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.